title: Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection.
authors.affiliation: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT 06102, USA.
authors.forename: C Andrew
authors.initials: CA
authors.lastname: DeRyke
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Kuti
authors.forename: Debra
authors.initials: D
authors.lastname: Mansfield
authors.forename: Adrian
authors.initials: A
authors.lastname: Dana
authors.forename: David P
authors.initials: DP
authors.lastname: Nicolau
mesh_terms: D000005:Abdomen / Q000503:physiopathology*; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics; D010878:Piperacillin / Q000008:administration & dosage / Q000191:economics*; D000078142:Tazobactam
chemical_list: D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin